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INTRODUCTION 
 
 
 
Chronic pancreatitis is a continuous or recurrent inflammatory disease of the 
pancreas characterized by progressive and irreversible morphological 
changes.It typically causes pain and permanent impairment of pancreatic 
function. Late in the course of the disease a progressive loss of endocrine 
and exocrine functions occur. 
 
 
 
 
 
AIM: 
 
To study the efficacy of imaging modalities like USG,CT, MRCP, and EUS 
in a case of chronic pancreatitis. 
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REVIEW OF LITERATURE 
 
 
 
Definition: 
 
Chronic Pancreatitis is defined as a progressive inflammation of 
the pancreas characterized by irreversible morphologic changes 
that typically causes pain and or permanent loss of exocrine and or 
endocrine function. Pain is the predominant feature and is 
associated with pancreatic calcification, diabetes and steatorrhoea. 
Chronic pancreatitis can lead to malignancy after many years.(1,2) 
 The newer imaging techniques like endoscopic ultrasonography 
(EUS), endoscopic retrograde pancreatography (ERCP), Magnetic 
resonance imaging changes are useful in detecting early changes in 
ducts and parenchyma. The identifications of genetic mutation 
associated with chronic pancreatitis like SPINK 1, CFTR, PRSS, 
have provided opportunities for identifying patients at risk for 
idiopathic pancreatitis. This review of literature will focus on 
epidemiology, classification of chronic pancreatitis, 
etiopathogenesis and genetic developments in chronic pancreatitis. 
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Incidence  
 
In chronic pancreatitis incidence found to be around 3 – 10 patients in 
100000 population. The prevalence is now estimated to be around 13 per 
100000 people(3). Idiopathic chronic pancreatitis is prevalent both in 
Western countries and India. Recent study shows that chronic pancreatitis 
previously classified as tropical pancreatitis represents idiopathic chronic 
pancreatitis in India. The true incidence and prevalence of chronic 
pancreatitis in India are not known(4).This is because studies related to 
idiopathic pancreatitis have been difficult to do because of insidious onset, 
difficulty in diagnosis, and the fact that the disease presents often as acute or 
recurrent pancreatitis without any definite evidence of chronic 
pancreatitis(5). 
 
Etiology: 
 
The exact etiology is partially known. Ethanol is considered as the 
commonest cause accounting for more than 50% of case along with other 
factors like hereditary, environmental anatomical variation, metabolic, 
genetics. Many classification systems have been proposed for chronic 
pancreatitis. These classification include, 
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i. The Marseille classification (1963) and revised Marseille 
classification in 1984(6). 
ii. The Marseille-Rome classification of 1988(7). 
iii. The Cambridge classification of 1984(8). 
iv. The Japan Pancreas Society classification for CP (9). 
v. TIGAR -O classification(10). 
 
TIGAR – 0 classification systems was proposed by Etemad and Whitcomb 
in 2001 and is based on primarily on the etiology of chronic pancreatitis and 
takes into account of newer developments such as genetic mutations. 
 
TIGAR -O Classification System for Chronic Pancreatitis  
 
Toxic Metabolic 
 Alcoholic  
 Tobacco Smoking  
 Hypercalcemia  
 Hyperlipemia  
 Chronic Renal Failure  
 
Idiopathic  
 Early onset  
 Late onset  
 Tropical  
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Genetic  
 Autosomal dominant: cationic trypsinogen gene mutation  
 Autosomal recessive / modifiers genes: CFTR mutations, SPINK1 
Mutations  
 
Autoimmune  
 Isolated autoimmune CP  
 Associated with other autoimmune diseases (Sjogren syndrome - 
associated CP) 
 
Recurrent and severe acute pancreatitis  
 Post - necrotic (severe acute pancreatitis)  
 Recurrent acute pancreatitis  
 Vascular disease / ischemic  
 Radiation injury  
 
Obstructive 
 Pancreas divisum  
 Sphincter of Oddi disorder (controversial)  
 Duct obstruction (e.g) tumour  
 Periampullary duodenal wall cysts  
 Post –traumic  
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Genetic : 
 
 
Until more recently few data existed on the genetic basis of chronic 
pancreatitis. The only known hereditary form of chronic pancreatic 
insufficiency that was well studied was cystic fibrosis. 
 
Research has focused on the SPINK1-N34S gene mutation, which also is 
associated closely with tropical (50%), alcoholic (6%), or idiopathic (20%) c 
chronic pancreatitis. 
 
One of the major discoveries in chronic pancreatitis was the description of 
the point mutation in patients with autosomal dominant hereditary 
pancreatitis. Several variants of the mutation of the cationic trypsinogen 
gene all lead to a malfunction of trypsinogen. Hereditary pancreatitis 
presents typically in a bimodal pattern of childhood and adulthood. 
Trypsinogen gene mutation found in hereditary pancreatitis which is an 
autosomal dominant disease carries 80% penetrance. 
 
Despite great advances in the knowledge of genetics in pancreatitis, 
currently it is advised to evaluate for mutations only in patients with 
hereditary pancreatitis. 
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Autoimmune : 
 
 
Autoimmune chronic pancreatitis (AIP) is a rare but distinct form of chronic 
pancreatitis that is associated with autoimmune features. AIP is 
characterized by specific histopathologic and immunologic features. The 
morphologic hall marks are periductal infiltration by lymphocytes and 
plasma cells and granulocytic epithelial lesions with consequent destruction 
of the duct epithelium and venulitis. 
 
The pathogenesis of AIP values a cellular CD4+ and CD8+ T cells) and 
humoral immune mediated attack of the ductal cells and pancreatic ducts 
resulting in cytokine mediated inflammation and periductular fibrosis, which 
leads to obstruction of the pancreatic ducts. 
 
AIP shows mild  abdominal pain and diffuse enlargement of the pancreas 
without calcifications or pseudocysts. 
 
On laboratory examination, these patients have hypergammaglobulinemia 
and autoantibodies, such as antinuclear and anti-smooth muscle antibodies. 
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Obstructive : 
 
 
Chronic pancreatitis results in block of the main pancreatic duct. The most 
common etiologies include scars of the pancreatic duct, tumors of the 
ampulla of Vater and head of the pancreas, and trauma. 
 
Stone and duct obstruction theory explains the stagnation of pancreatic juice 
and stone formation  or acute recurrent pancreatitis and periductular fibrosis 
(necrosis fibrosis theory). Histopathologic characteristics of chronic 
pancreatitis resulting from obstruction include uniform distribution of 
interlobular and intralobular fibrosis and marked destruction of the exocrine 
parenchyma in the territory of obstruction, without significant protein plugs 
and calcifications. 
 
Chronic pancreatitis results from plugging of the pancreatic duct. The origin 
of chronic pancreatitis was within the lumen of the pancreatic ductules in 
contrast to the origins of acute pancreatitis which tends to be inside the 
acinar cell. Increased lithogenicity of pancreatic fluid leads to the formation 
of eosinophilic proteinaceous aggregates, which precipitate and obstruct the 
pancreatic ductules. 
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Alcohol decreases the formation and the secretion of pancreatic juice, 
making it more viscous ; low in bicarbonate ; rich in protein, enzymes and 
calclium crystals ; and deficient in lithostatin. 
 
Alcohol also has been shown to mediate the release of gastrointestinal 
hormones by increasing cholecystokinin releasing factor, which affects 
pancreatic juice formation and flow. The pancreatic stones and plugs are 
believed to produce ulceration of the ductal epithelial cells resulting in 
inflammation, obstruction, stasis, fibrosis which leads to formation of stones. 
 
Mechanism of chronic pancreatitis was a dysregulation and increased 
activity of the hepatic mixed function oxidases leading to oxidative stress. 
This theory places the acinar cell at the major area of injury by oxidative 
stress, usually as a result of steady exposure of xenoiotics that induce the 
cytochrome P-450 enzymatic system, while depleting glutathione. 
 
Pancreatitis is triggered through interference of the methionine to glutathione 
transsulfuration pathway, resulting in diversion of free radicals in to the 
pancreatic tissue, with consequent activation of inflammation and fibrosis of 
the ductules with low flow of pancreatic juice, inhibition of lithostatin, and 
precipitation of proteins and calcium (Braganza 1998 ; Wilson et al, 1990). 
Alcohol also may contribute to increase the oxidative stress resulting from 
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depletion of scavengers, such as selenium, vitamin E and C and riboflavin, 
and help to induce or propagate the damage. 
 
Alcohol and its toxic metabolites cause accumulation of intracellular lipids 
and fatty acid ethyl esters, which produce damage to the acinar cell. The 
alterations of intracellular lipid metabolism lead to fatty degeneration, 
apoptosis and scarring of the pancreatic parenchyma with impairment of the 
pancreatic microcirculation. 
 
It was shown that these fat cells exists in the human pancreas, can migrate 
into the periacinar spaces, and are activated by alcohol and acetyl aldehyde, 
transforming into scar producing cells. The necrosis fibrosis hypothesis 
views the development and course of chronic pancreatitis as a consequence 
of severe pancreatitis, emphasizing that fibrosis is a late development 
resulting from repeated attacks of acute (alcoholic) pancreatitis, which 
initially lead to inflammation and necrosis. 
 
The necrosis fibrosis hypothesis has significant supporting evidence from 
epidemiologic and large follow up studies, which showed recurrent attacks 
of acute pancreatitis leads to chronic pancreatitis. 
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The recurrent attacks of acute pancreatitis in hereditary pancreatitis also 
support the necrosis fibrosis hypothesis. One important aspect that partially 
negates this hypothesis is the fact that the type of fibrosis that follows acute 
attacks of pancreatitis involves short lived collagen type III and procollagen 
type IV and not the long lasting collagen types I and IV (Casini et al 2000).  
 
The primary pathogenic factor leading to chronic pancreatitis is an outflow 
obstruction likely resulting from duct inflammation, destruction and fibrosis 
which likely are the result of an immunologic attack on a specific genetic, 
structural or acquired antigen of the periductular epithelium. The target of 
this attack may be some specific genetic or acquired antigen on the duct 
epithelium. 
 
Chronic pancreatitis seems to be an autoimmune or duct destroying disease, 
analogous to primary sclerosing cholangitis. The assumption is supported by 
several observations, such as the radiologic and histologic similarity of 
chronic pancreatitis and primary sclerosing cholangitis, the activation of 
cytotoxic T.lymphocytes in the periductular areas of the pancreas in patients 
with alcoholic chronic pancreatitis, and the occasional association of chronic 
pancreatitis and primary sclerosing cholangitis. 
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The SAPE hypothesis tries to provide a “final common pathway” for the 
many etiologies for pancreatitis. The basic aspect is that there needs to be 
susceptibility (genetic or through ongoing insult, such as alcohol toxicity). 
The critical sentinel event appears and triggers the process causing acute and 
chronic pancreatitis. Further activation of the immunologic system and the 
stellate cells propagates chronic pancreatitis, and the end result is fibrosis 
and calcifications. 
 
PATHOGENESIS 
 
Current theories for pathogenesis of chronic pancreatitis can be broadly 
divided into two types  
 
1. Duct obstruction theory-Alterations in the physical and chemical 
properties of pancreatic secretions which leads to duct obstruction as 
the main cause of pancreatic damage. 
2. Toxic metabolic theory- continuous injury to pancreatic acinar cells 
produces inflammation, necrosis, and fibrosis with duct obstruction . 
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Progression from pre-acute pancreatitis to chronic pancreatitis (11). 
 
 
 
Pre-acute pancreatitis  
 
 
 
 
 
 
 
Acute pancreatitis  
 
 
 
 
 
 
 
 
 
 
 
    Mild acute pancreatitis   Severe acute pancreatitis 
 
 
 
 
 
Post-acute pancreatitis  
 
 
 
 
 
 
 
Chronic Inflammation / Scarring 
 
 
 
Chronic Pancreatitis  
Risk Factors 
- Genetic, alcohol 
- Metabolic factors 
 
Sentineal acute pancreatitis event - SAPE 
- Proinflammatory phase 
- Antiinflammatory phase 
Progression 
Recurrent acute pancreatitis Chronic stressors 
- SPINK1   - Alcohol, smoking 
- CFTR 
- PRSS1 
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RECENT CONCEPTS 
 
Two important concepts have emerged as being important in the 
pathogenesis of CP including the so-called TCP. These include oxidative 
stress and genetic mutations.  
 
Oxidative Stress 
 
Oxidative stress (OS) has been implicated recently in the pathophysiology of 
CP(12-13). Xenobiotics are detoxified in the body through phase I and phase 
II pathways chiefly in the liver(14). Increased exposure to alcohol, nicotine, 
petrochemical fumes may overwhelm the capacity of phase I and phase II 
detoxification pathways and result in oxidative stress. OS will damage these 
cell either directly by cell membrane destruction, depleting the cells of 
antioxidants or free radical mediated injury(15-16).  
 
Genetic Mutation: 
 
The role of genetic mutations in CP has been studied for more than 30 years. 
Initial studies were directed toward the association of HLA genes with 
pancreatitis. In 1950s, Comfort et al(17) described Heridatary Pancreatitis as 
a highly penetrant, autosomal dominant condition. In 1998, studies showed 
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an increased incidence of CFTR gene mutations in patients who had 
idiopathic CP(18-19). In a landmark study, Whitcomb et.all50. reported 
arginine to histidine substitution at residue 117 (subsequently renamed as 
R122h) in the cationic trypsinogen gene on the long arm of chromosome 7 
(7q35) in hereditary pancreatitis. Witt and colleagues said that mutations in 
the SPINK 1 gene were associated with CP(20). The discovery of 
heterozygotes individuals with mutations in multiple genes and the resultant 
additive effect on disease underscores the complex nature of genotype and 
phenotype expression in CP 
 
Idiopathic chronic pancreatitis (21) 
 
Idiopathic chronic pancreatitis includes in whom no risk factors can be 
found. The discovery of new genetic factors, environmental factors and 
metabolic factors will reclassify - and reduce the numbers of patients in this 
category. Idiopathic chronic pancreatitis has long been shrouded in mystery 
as far as its etiopathogenesis is concerned. Many different theories have been 
proposed like immune-mediated injury and environmental toxins however 
newer studies have discarded above hypothesis. Idiopathic CP that is 
common in India is also known by some authors as tropical calcific 
pancreatitis (22). 
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Early and late onset 
 
The age of onset in idiopathic pancreatitis is bimodal as observed by Layer 
et al. In early onset calcification and exocrine and endocrine deficiency 
develops slowly than late onset. In late onset pain was absent in nearly 50% 
of patients. Pbtizone (23) identified SPINK 1 mutation in about 25% of 
patients with idiopathic chronic pancreatitis. Patients with SPINK1 mutation 
developed pancreatitis before age of 20 in many studies. 
 
Tropical Chronic Pancreatitis 
 
Tropical chronic pancreatitis is known as a type of idiopathic CP occurring 
in tropical countries. They can be sub-grouped as Tropical calcific 
pancreatitis. TCP Characterised by frequent episodes of pain abdomen in 
childhood, extensive pancreatic calcification and pancreatic dysfunction but 
no diabetes at time of diagnosis. The other group is called as fibrocalculous 
pancreatitis diabetes (FCPP) in which diabetes mellitus is the first major 
complaint(24). The etiology of tropical calcific pancreatitis is poorly 
understood. Many theories such as environmental factors, malnutrition, 
dietary Toxin like cyanogenic glycosides and micronutrient deficiency have 
been proposed. Recent reports from genetics studies have shown significant 
association between (SPINK1 and cationic trypsinogen mutation). 
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CLINICAL FEATURES 
 
Recurrent acute Pancreatitis(25) 
 
All patients have recurrent attacks of upper abdominal pain at the onset. The 
pain is accompanied by nausea and vomiting in around 90% of patients. 
Patients can also present with severe pancreatitis which is associated with 
organ failure. 
 
Chronic Pancreatitis 
 
Abdominal pain is the common presenting symptom localized to the 
epigastric region. The natural history of pain is highly variable and can 
present as intermittent or chronic pain. The other symptoms include diarrhea, 
weight loss, endocrine insufficiency (diabetes), jaundice or complications of 
acute episodes. The physical examination does not help to establish 
diagnosis however fullness, tenderness can be elicited. Patients with 
advanced disease show signs of malnutrition 
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Approach to Determine etiology of recurrent Pancreatitis: 
 
Evaluation of a patient after the first attack of pancreatitis includes a careful 
history, lab studies (lipid profile, serum calcium, Anti nuclear anti body, 
Liver function tests) and USG abdomen(26,27). Half of the patients with 
acute pancreatitis will have a recurrence. EUS / MRCP should be done to 
identify gall bladder sludge, small CBD stones, pancreas divisum, pancreatic 
tumors and early chronic pancreatitis. In clinical practice, ERCP is seldom 
done. For patients with idiopathic acute pancreatitis, selective use of genetic 
testing may be appropriate. For the patient with RAP, especially in the 
setting of an appropriate family history, genetic testing for cationic 
trypsinogen gene (PRSS1), SPINK 1 gene can be done. The role of genetic 
testing for these mutations is less clear and controversial. 
 
Chronic Pancreatitis: 
 
The diagnostic approach to chronic pancreatitis has evolved considerably in 
recent years. The investigations used can be summarized as below: 
 Imaging of pancreas and pancreatic ducts.  
 Tests for pancreatic exocrine insufficiency: to assess the degree of 
exocrine dysfunction (e.g., fecal chymotrypsin) and sometimes to 
monitor replacement therapy (e.g., fecal fat estimation).  
 Tests for pancreatic endocrine deficiency.  
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Biochemical Blood Tests  
 
Serum trypsin exists mainly as the cationic form of its precursor trypsinogen. 
In states of pancreatic insufficiency, the precursor gets converted to active 
trypsin. The active trypsin is mostly bound by protein inhibitors and become 
undetectable by catalytic assays (28). The study by pezzilli (29) et all has 
found it to be 28% sensitive but 100% specific in identifying chronic 
pancreatitis. However, other studies have shown it to be only 50-60% 
sensitive in detecting chronic pancreatitis. Serum lipase and amylase levels 
are elevated during acute pancreatitis but are of limited value to diagnose 
chronic pancreatitis.  
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IMAGING METHODS: 
 
Plain X ray : 
 
A plain x ray abdomen ,though not by itself diagnostic of chronic 
pancreatitis,can detect calcification in the pancreatic area.Pancreatic 
calcification is more commonly associated with alcoholic and tropical 
pancreatitis.X ray abdomen is of limited value as a diagnostic measure 
because CT scan can demonstrate calcium deposition as well as other finding 
associated with chronic pancreatitis. 
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Transabdominal Ultrasonography 
 
Transabdominal ultrasonography can be used to visualize alterations of the 
pancreatic duct, pancreatic calcification or stones and pancreatic cysts or 
pseudocysts. Pancreatic stones are visible as intra-pancreatic hyper-reflective 
echoes with acoustic shadows.Dilatation of the pancreatic duct can be seen 
more clearly in the head and body of pancreas rather than in the tail 
region.Abdominal ultrasound is highly sensitive in detecting severe chronic 
pancreatitis but the sensitive is much less in milder forms of the disease(30). 
 
Computed Tomography (CT) Scan(31) 
 
Computed tomography scan is one of the important diagnostic modalities in 
detection of chronic pancreatitis. In chronic pancreatitis, a non-contrast-
enhanced CT scan shows chronic pancreatitis. The contrast-enhanced 
pancreatic imaging produced by thin-multidetector row scanners can detect 
any abnormality in the morphology of the gland, any parenchymal 
attenuation, any dilation or stones in the pancreatic duct and pancreatic 
pseudocysts.It can also identify vascular complications such as 
pseudoaneurysms, and venous thrombosis of the splenic or 
pancreaticoduodenal artery(32). 
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CT scan is as specific as ultrasound but more sensitive. CT scan cannot 
detect early parenchymal changes and effects on small pancreatic ducts, but 
advanced stages and complications of the disease can be evaluated with high 
reliability. CT is most sensitive to detect calculi. CT is excellent method to 
detect advanced stage but not for early stage of chronic pancreatitis. 
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CT GRADING 
 
GRADE CT FINDING 
Normal No abnormal findings 
equivocal 
one of the following 
mild dilatation of pancreatic duct(2-4mm) 
gland enlargement<2-fold normal 
mild-moderate 
pancreatic duct dilatation(>4mm) 
focal necrosis or parenchyma 
cavity<10mm 
increased echogenicity of duct wall 
severe 
cavity>10mm 
intraductal filling defect 
calculi/pancreatic calcification 
ductal obstruction(stricture) 
severe duct dilatation or irregularity 
 
Magnetic Resonance Imaging (MRI)(33) 
 
Magnetic resonance imaging cannot detect extraductal pancreatic 
calcification as well as CT scan can. Both T1and T2 weighed images may be 
used to detect severe forms of chronic pancreatitis, though the findings are 
less specific in the elderly patients. 
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MRCP can provide a 3- dimensional image of main pancreatic duct which 
provides valuable information about strictures, dilatations and filling defects. 
It is superior to ERCP in demonstrating the upstream of pancreatic duct 
distal to an obstructing lesion. 
Secretin -enhanced MRCP can also assess the exocrine function of pancreas.  
 
                      
 
Endoscopic Retrograde Cholangiopancreatography(ERCP) 
 
ERCP can be used as a diagnostic as well as therapeutic tool in patients with 
chronic pancreatitis. It can detect dilatation and stenosis of pancreatic ducts, 
pancreatic stones or cysts. 
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However, as ERCP can be associated with iatrogenic acute pancreatitis, it is 
not preferred as a diagnostic modality. ERCP may be useful in 
distinguishing chronic pancreatitis from pancreatic cancer. 
 
ERCP used to treat calcific obstruction of distal, main pancreatic duct and 
drain symptomatic pancreatic pseudocysts. Also used to remove pancreatic 
calculi, dilate strictures and insert stents. 
 
ERCP is less sensitive than other modality to detect small duct disease.   
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Cambridge classification 
 
Grade Main pancreatic duct Side branches 
Normal Normal Normal 
Equivocal Normal <3 abnormal 
Mild Normal >=3 abnormal 
Moderate Abnormal >=3 abnormal 
Severe Abnormal with at least one of 
the following  
large cavity(>10mm) 
obstruction  
filling defect 
severe dilatation or irregularity 
>=3 abnormal 
 
ERCP demonstrating severe chronic pancreatitis. 
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Endoscopic Ultrasonography (EUS)(34) 
 
Endoscopic ultrasound is the diagnostic modality of choice to evaluate 
patients with early or mild chronic pancreatitis. EUS helps enables the 
clinician to assess the pancreatic parenchyma as well as the pancreatic duct. 
Parenchyma features include atrophy, hyperechoic foci, stranding, cysts and 
lobularity. The ducts are studied for narrowing, dilation, irregularity, calculi, 
side-branch dilation and hyperechoic walls. 
 
EUS is considered superior to ERCP or MRCP for detection of early or mild 
changes of chronic pancreatitis as well as small duct involvement. EUS can 
also be used as a guide to fine needle aspiration of focal pancreatic lesions to 
differentiate inflammatory and malignant mass lesion. (35) 
Parenchymal abnormalities 
Hyperechoic foci 
Hyperechoic strands 
Lobularity of contour 
Cyst  
Ductal abnormalities 
Main duct dilatation 
Main duct irregularity 
Hyperechoic ductal walls 
Visible side branches 
Calcification 
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Sensitivity and specificity of Radiological and Endoscopic Investigation in 
Chronic Pancreatitis 
 
Test Sensitivity Specificity 
Plain x ray abdomen - - 
ultrasound abdomen - - 
CT abdomen 75-90 85 
ERCP 75-90 90 
MRCP 85 100 
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TREATMENT 
 
The treatment of chronic pancreatitis is complex and often an 
interdisciplinary approach is indicated with the possibility of conservative 
medical, endoscopic and Surgical therapy. 
 
Management options for chronic pancreatitis include medical, endoscopic 
and surgical treatments. Patients with chronic pancreatitis seek medical 
attention because they suffer from abdominal pain, weight loss or diabetes. 
 
Treatment of Pain(36,37) 
 
The pathophysiology of pain in chronic pancreatitis is incompletely 
understood. The proposed theories are ductal and mechanical mechanism, 
neuropathic, oxidative stress and central mechanism of pain. The 
management of pain in chronic pancreatitis is frustrating both for patients 
and clinicians. The following tables summarize the management of chronic 
pancreatitis. 
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Mechanisms of Pain in Chronic Pancreatitis and Management Options(38) 
 
Proposed mechanism of pain Management options 
Duodenal Obstruction  Surgical bypass or endoscopic stent 
Bile duct obstruction Endoscopic stent or surgery 
Pseudocyst Endoscopic, surgical or percutaneous drainage 
Pancreatic duct obstruction 
(stone or stricture) 
Endoscopic or surgical ductal decompression 
Tissue hypertension and 
ischemia 
Antioxidants, endoscopic and surgical ductal decompression 
Intra-pancreatic nerve injury Celiac plexus block or neurolysis 
Visceral nerve sensitization Tricyclic antidepressants, SSRI, combined serotonin and 
norepinephrine re-uptake inhibitors 
Central nerve sensitization Tricyclic antidepressants, SSRI, combined serotonin and 
norepinephrine re-uptake inhibitors 
Elevations in cholecystokinin Non-enteric coated pancreatic enzymes 
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Options for Medical Management of Pain in Chronic Pancreatitis(36, 37) 
Agent Dose 
Propoxyphene with acetaminophen 1 - 2 p.o. q.8h. 
Tramadol (50 mg) 1 - 2 p.o. q.8h. 
Antioxidants A combination of 500 – 1000 mg of Vit C, 250-
300 IU of Vit E, 500 – 800 ug of selenium, 2 g 
of methionine, 9000 – 10,000 IU of beta 
carotene per day in divided doses 
Tricyclic antidepressants Amitriptyline (start at 25 mg q.h.s.) 
Pancreatic enzymes Non enteric coated, protease content 25,000 – 
50,000 USP with each meal Co- treatment with 
H2 blockers and PPI if needed to prevent 
degradation by gastric acid 
 
Pancreatic exocrine enzyme supplemention : 
 
When weight loss or steatorrhea (15g/day) or both develop supplementation 
is indicated. Enzyme supplementation is given so that good amounts of 
lipase reach duodenum along with the food. With the currently available 
pancreatic enzymes supplement preparation azotorrhea can be abolished, 
whereas steatorrhea can be reduced but not totally corrected. Side effects are 
rare except soreness of mouth, perianal irritation, abdominal pain, diarrhea, 
constipation, allergic reaction and fibrosing colonopathy in cystic firbrosis 
patiet. Dose of lipase: 2500 u lipase / kg body weight per meal. 
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Antioxidant therapy:(39) 
 
There is significant pain relief with antioxidants in patients with alcoholic 
pancreatitis, and it leads to a significant decrease in oxidative stress in these 
patients supporting oxidative stress hypothesis. Antioxidant used was a 
combination of organic selenium, ascorbic acid, beta-carotene, tocopherol, 
methionine per day in divided doses. Antioxidants have emerged as effective 
therapy for CP. 
 
Supportive measures in managing patients with chronic pancreatitis include 
diet and pain medications. The diet should be moderate fat (30%), high 
protein (24%) and low carbohydrate (40%) content. Patients with partial 
obstruction could benefit from addition of promotility agents. 
 
Pancreatic Enzyme Replacement Therapy (PERT): 
 
Pancreatic enzyme replacement therapy in chronic calcific pancreatitis is 
offered to all patients with symptoms. The dose is adjusted according to 
response .Starting with high dose 100,000 -150000 IU/day in divided dose 
taken along with food and stepped down to least possible dose to alleviate 
the symptoms . Proton -pump inhibitors should be given to every patient 
who is on PERT. The possibility of pancreatic decompression either 
endoscopically or surgically should be done in patients with intractable pain. 
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Endoscopic Treatment : 
 
The aim is to relieve the pain and treat the complications associated with the 
disease. The advantage of endotherapy - high success rate and low 
morbidity. The various options according to the various scenario are 
described below 
 
Endoscopic Pancreatic Sphincterotomy (EPS): 
 
This is the only documented mode of therapy in patients with CP who have 
mild to moderate pancreatic duct changes even in the absence of ductal 
obstruction. There are two types pull type and needle knife sphincterotomy. 
These are done over a stent.Restenosis is less common following long 
incision of pull type sphincterotomy (40). Complications include 
pancreatitis, bleeding and perforation.(41) 
 
Endoscopic Management of Pancreatic Duct Stricture 
 
Stricture of the MPD and resultant upstream hypertension is one of the 
common cause for pain.Stricture could be due to inflammation or fibrosis.  
MPD stricture is defined as high grade narrowing with one of the following 
1) MPD  dilatation >6mm beyond the stricture 
2) Failure of contrast to flow alongside a 6 Fr nasopancreatic catheter 
3) Presence of pain during continuous perfusion of the catheter with normal 
saline for 12- 24 hours. 
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Dilatation of tight stricture is carried out with teflon bougies or balloon 
dilator following a large bore stent .There is no definite protocol for stent 
diameter, duration or number of stent to be placed. 
 
Endoscopic Treatment of Pancreatic Duct Stones 
 
PDS are the end result of CP in up to 50% patients. Stones <5mm can be 
generally extracted with Dormia basket or balloon following EPS. Stones 
larger than >5mm are often impacted and difficult to extract, these stones 
need to be fragmented using ESWL before extraction. The aim of 
fragmentation is to break the calculi to fragments of 3mm or less. In select 
group of patients with large calculi, ESWL is a useful tool for fragmentation 
and this is followed by endotherapy helps in PD clearance and pain relief of 
pain. 
 
Endoscopic Management of CBD Stricture Secondary to CP 
 
Biliary drainage is indicated when the patient has jaundice, cholangitis. 
Biliary drainage is advised as it can lead to secondary biliary cirrhosis. The 
different types of stents used are plastic stents, self-expanding metal stents 
(SEMS)-uncovered, covered and partially covered. 
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Endoscopic Management of Pancreatic Duct Leaks 
 
PD leaks occur as a result of blow out of the duct following obstruction by a 
stone or stricture. It could be partial or complete and leaks lead to fluid 
collection, pseudocyst, ascites or an external or internal fistula. Trans 
ampullary stent placement offers the best treatment as it converts the high 
pressure ductal system into a low pressure one with preferential flow across 
the stent. 
 
Endoscopic Management of Pseudocyst 
 
Treatment is reserved for symptomatic pseudocyst or those increasing in 
size. Smaller cyst can be followed up.Pseudocyst can be approached 
transmural or the transpapillary route. Complications include bleeding 
,infection or leak with mortality around 0.5%. Endoscopic drainage of 
pseudocyst is the preferred first line of treatment with a good success rate. 
 
Major limitations of endoscopic intervention are stent clogging, migration 
and cholangitis.  
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SURGERY : 
 
The principle of surgery in CP is to achieve long lasting pain relief, treat 
local complications, preserve pancreatic function with improvement in 
quality of life. Several patients undergoing surgery may have more than one 
indication for surgery and the procedure must be tailored accordingly. 
Indications for surgical intervention 
1. Intractable pain. 
2. Suspicion of malignant neoplasm. 
3. Persistent bile duct and duodenal obstruction. 
4. Vascular complications not controlled by radiology. 
5. Left sided portal hypertension not controlled by endotherapy. 
6. Pseudocyst not ammenable to endotherapy. 
 
Two types of surgical intervention are available : drainage and resection 
procedure. “Hybrid operations” such as Freys, Izbicki operation and 
modification of Beger operation in an attempt to combine resection and 
drainage procedure. 
 
Two less commonly performed operation are denervation and pancreatic 
autotransplantation.  
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Drainage procedure : 
 
Rationale for drainage procedures 
1. Decompressing the dilated, hypertensive ductal system 
2. Reducing the intrapancreatic parenchymal pressure 
3. Restoring pancreatic blood flow 
 
Puestows drainage procedure reported good results with longitudinal 
decompression of body and tail by a Roux limb ensuring wider drainage 
.However these are all partial drainage procedures.  Partington and Rochelle 
described a refined technique of Puestow procedure. It consists of a side to 
side long pancreaticojejunostomy, at least 10 cm without resection of the 
pancreatic tail.  
 
Patient with a dominant mass in the head of the pancreas and a dilated 
pancreatic duct do not profit from a drainage procedure only. In addition to 
the drainage approach Beger and Izbicki proposed excavation of the head of 
the pancreas or the V shaped exacavation of the body along the main 
pancreatic duct followed by a pancreaticojejunostomy. 
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Resection procedures : 
 
Whipple’s procedure, Pylorus preserving pancreatico duodenectomy, Beger 
procedure, Berne modification of the Beger procedure (DPPHR) are the 
various resection procedure with merits and demerits. 30-50% patient of CP 
have pancreatic head enlargement. The head is considered the pace maker in 
CP and procedures which addressed the problem in the head have shown 
superior pain relief compared to duct drainage alone. 
 
Beger’s procedure (DPPHR) preserved the duodenum when compared to the 
whipples procedure, which was the standard procedure in patient with 
chronic pancreatitis for a long time. Patient who underwent Beger Procedure 
had greater weight gain, better glucose tolerance and high insulin secretion 
capacity. Improved pain status, lower frequency of acute episodes of chronic 
pancreatitis, rate need for further hospitilization, low early and late mortality 
rates and restoration of quality of life, DPPHR seems to be able to delay the 
natural course of the chronic pancreatitis. 
 
Frey procedure which involve local pancreatic head excision. combined with 
longitudinal pancreaticojejunostomy can be considered as a standard 
procedure in chronic pancreatitis and has under gone evaluation in multiple 
trails, confirming its effectiveness as a surgical procedure for chronic 
pancreatitis. 
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Frey’s Procedure  
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MATERIALS AND METHODS 
 
Study Design 
 
Prospective and observational analysis of patients with chronic pancreatitis 
admitted in PSG Hospital, Coimbatore, during the period Jan 2011 - June 
2012. 
 
Study Population 
 
Study will be conducted in 30 patients with chronic pancreatitis admitted in 
PSG Hospital in general surgery and medical gastroenterology departments. 
 
Ethical approval: 
 
The study protocol was approved by the Institute Human Ethics Committee 
(IHEC) prior to the start of the study. 
 
Inclusion Criteria 
 
All chronic pancreatitis patient admitted in our hospital will be included in 
the study. 
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Exclusion Criteria: 
1. Patient’s with previous history of surgery for chronic pancreatitis. 
2. Chronic pancreatitis in children. 
3. Malignancy.  
4. Patient who do not consent. 
 
Diagnosis of chronic pancreatitis: 
The diagnosis of chronic pancreatitis was made based on clinical setting and 
evidence of pancreatic duct dilatation, irregularity and/ or pancreatic 
calcification on imaging studies. 
 
Work up 
All patients underwent complete blood counts, biochemical investigations 
including liver function test, renal function, fasting blood sugar, serum 
calcium, lipid profile, serum amylase and lipase. The following imaging 
studies were done relevant to the individual patients 
1. Transabdominal ultrasonography.  
2. Contrast enhanced CT abdomen. 
3. MRCP / EUS if indicated. 
Complications of Chronic Pancreatitis like diabetes mellitus, steatorrhoea, 
bile duct obstruction, pseudocyst were diagnosed as per standard criteria 
either biochemically or imaging. 
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RESULTS 
 
Males are affected more than female patients. 
Gender Classification 
 
Gender Frequency Percent 
Male 22 73.3 
Female 8 26.7 
Total 30 100.0 
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Age Classification 
 
There were 30 patients included with the youngest being 18 years  and oldest 
being 62 years male .Most patients presented in their 3rd decade of life. 
 
Age Frequency Percent 
Less than 20yrs 1 3.3 
21 to 30 yrs 2 6.7 
31 to 40 yrs 14 46.7 
41 to 50 yrs 7 23.3 
51 to 60 yrs 4 13.3 
61 to 70 yrs 2 6.7 
Total 30 100.0 
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Etiology 
 
The common etiological factor was alcohol followed by idiopathic 
pancreatitis. 
 
Etiology Frequency Percent 
Idiopathic 11 36.7 
Alcohol 16 53.3 
Hyperlipidemia 1 3.3 
Autoimmune 2 6.7 
Total 30 100.0 
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Clinical Data 
 
Nearly 24 /30 patients had pain as their clinical symptoms  
 
Clinical Data Frequency Percent 
Abdominal pain 13 43.3 
Diabetes 5 16.7 
Abdominal pain & Diabetes 8 26.7 
Steatorrhoea 1 3.3 
Abdominal pain & Jaundice 1 3.3 
Abdominal pain, Diabetes & Jaundice 2 6.7 
Total 30 100.0 
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Physical findings 
 
Most of the patient presented with epigastric tenderness 80%. 
 
Physical findings Frequency Percent 
Epigastric Tenderness 24 80.0 
Splenomegaly 2 6.7 
Hepatomegaly 3 10.0 
Epigastric Mass 1 3.3 
Total 30 100.0 
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Imaging 
 
Ultrasound and MRCP was the commonly done imaging. 
 
Imaging Frequency Percent 
USG Abdomen 3 10.0 
CT Abdomen 2 6.7 
USG & CT Abdomen 7 23.3 
MRCP 6 20.0 
USG & MRCP 10 33.3 
USG & EUS 2 6.7 
Total 30 100.0 
 
Imaging Frequency Percent 
USG Abdomen 22 73.3% 
CT Abdomen 9 30% 
MRCP 16 53.3% 
EUS 2 6.7% 
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Outcome 
 
Medical management is the first line of treatment. 
 
Outcome Frequency Percent 
Surgery 5 16.7 
Endoscopic 1 3.3 
Medical 24 80.0 
Total 30 100.0 
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DISCUSSION 
 
The current study is a prospective analysis of 30 patients diagnosed to have 
chronic pancreatitis.  
 
The mean age of CP in our study was 38.5 years,the youngest being 18 and 
oldest being 62 yrs.A study by Balakrishnan (42)et al showed mean age of 
patient was  32 years. 
 
Majority of patients with idiopathic chronic pancreatitis (ICP) were young 
with mean age of 33.0 ± 13.0 years whereas patients with alcohol related 
chronic pancreatitis were significantly older than patients with ICP with the 
mean age of patients with alcohol induced chronic pancreatitis being 41.5 ± 
9.9 years . 
 
Majority of the patients in our study were male (73.3%).Data from 
prospective nationwide study from India showed male prepordance. Study 
by Balakrishnan(42)et al showed male to female ratio of 2:7:1. A study from 
Delhi and Lucknow showed majority of their patients with tropical 
pancreatitis were males. 
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In our study alcohol(53.3%) is the most common etiology followed by 
idiopathic(36.7%).Study in brazil observed 797 consecutive cases of chronic 
pancreatitis from 1963 to 1987 in the cities of Belo Horizonte and São Paulo. 
Alcoholism was the main etiological agent, responsible for 714 cases 
(89.6%). (43) 
 
Pain was the common presentation in our study which was similar to other 
studies by Layer et al(44). Balakrishnan et al(42). Shallu midha et al(45) 
reported 97 % presented with pain which was almost similar to our data. 
 
Diabetes was seen in 48% patient in our study which is different from study 
conducted by Geeverghese(46) and Tandon et al who in their study showed 
upto 90% of patients having diabetes. The study by Balakrishnan(42) et al 
showed higher incidents of diabetes upto 70%. The study from Lucknow 
reported diabetes in 26% of patients with idiopathic chronic pancreatitis. 
Midha et al(45) also reported 27% patients having diabetes in chronic 
idiopathic pancreatitis. 
 
In our study 80% of patients presented with epigastric tenderness which is 
the same in a study done by Midha S et al (45) which has reported more than 
90% present with epigastric tenderness. 
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Ultrasound was done in 22 patients in our study of which only 50-60% are 
diagnostic. Parenchymal calcifications are missed only the ductal 
calcification and the dilatation are picked up as well the complications .The 
ultrasound has a lower sensitivity in detecting pancreatic calcifications than 
computed tomography. Study from all India institute of medical science 
showed usefulness of ultrasonographic evaluation of calcific pancreatitis. 
 
Ultrasound is first line imaging modality used in CP. It is simple, 
noninvasive, easy to perform.  In routine clinical situation, USG is the 
easiest method to detect the complication of chronic pancreatitis and to 
follow patients with chronic pancreatitis. Use of ultrasound for diagnosing 
chronic pancreatitis is limited to advanced stage. 
 
In our study CT was done in 9 patients (29%) with specificity of 80%.In our 
study 87.87% had parenchymal calcification 75% had ductal dilation and 
only 21% had ductal calculi. 
 
CT is more sensitive in identifying ductal dilatation and calcification .CT is 
more sensitive when compared to USG abdomen. CT scan cannot detect 
early parenchymal changes and effects on small pancreatic ducts, but 
advanced stages and complications of the disease can be evaluated with high 
reliability. CT is most sensitive to detect calculi. 
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CT remains the best screening tool for detection of chronic pancreatitis and 
exclusion of other intra abdominal disorders that may cause symptoms 
indistinguishable from chronic pancreatitis on clinical grounds alone. 
 
Charnley et al(47) have found that CT cannot detect early changes of chronic 
pancreatitis or define the degree of ductal abnormality, whereas MRCP is 
more specific for ductal abnormality . 
 
MRCP was done in 16 patients (53%) with specificity of 100% in our study. 
In our study 6 patients had ductal calculi and the remaining had ductal 
dilatation and atrophy of the pancreas.  
 
The advantage of this modality is noninvasiveness. MRCP is replacing 
ERCP as a non-invasive diagnostic modality with main pancreatic duct 
involvement. Calvo et al (48)have found it to be more than 85% sensitive 
and 100% specific in detecting abnormalities of the main pancreatic duct. 
The incidence of Pancreatic Duct Stones (PDS) is less than 1% in normal 
population, while it is about 30% in CP patients(49). PDS can lead to the 
damages of pancreatic tissues and corresponding clinical symptoms(50-51). 
It was reported that 12%-22.2% of PDS patients finally develop pancreatic 
adenocarcinoma (52-53). Therefore, early diagnosis of PDS is of very 
important clinical significance. 
 54 
 
Compared with other imaging techniques, MRCP is easy to perform and has 
no contraindication. It could provide detailed information about pancreatic 
duct and common bile duct. Therefore, MRCP is widely applied in the 
diagnosis of PDS. 
 
MRCP was considered less sensitive in detection of side branch abnormality, 
which is a frequent finding in CP. It has also limited application in detection 
of milder forms of the disease. Secretin enhanced MRCP is more sensitive 
and specific to MRCP alone in detection of early CP. In conclusion, secretin 
injection-MRCP might allow an earlier diagnosis of chronic pancreatitis and 
reduce the rate of false-negative cases detected with MRCP. 
 
ERCP is considered as a gold standard to diagnose early chronic pancreatitis. 
ERCP is, at present, the most sensitive diagnostic method for evaluation of 
early changes in the main pancreatic duct and its side branches. ERCP is 
considered invasive diagnostic modality and the risk for iatrogenic 
pancreatitis is more. MRCP may probably become a valid, noninvasive 
alternative to diagnostic ERCP in patients with mild pancreatic disease. 
ERCP is reserved for therapeutic purpose only. 
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ERCP is done in 1 patient as a therapeutic procedure for removal of small 
duct stones and placement of stent in Main Pancreatic Duct (MPD). 
 
As the 5 patient who underwent surgery had large ductal calculi . In our 
setup as ESWL is not available, surgery is done for these patients. 
 
Stones <5mm can generally be extracted with Dormia basket or balloon 
following Endoscopic Pancreatic Sphincterotomy(EPS).However , stones 
>5mm are often impacted and difficult to extract by these technique. 
 
Tandan M, Reddy V,et al (54) showed patients with large pancreatic duct 
calculi in the head and body region with pain are subjected to fragmentation 
prior to expulsion using ESWL .Significant relief in pain score and decrease 
in analgesic requirement were seen in 84% of patients on short term follow 
up.  
 
The outcome in our study, out of 30 patients 24 (80%)underwent medical 
management and only 5 (16%)underwent surgery. 
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Modified Puestow’s is the most commonly performed surgical drainage 
procedure and has good results in pain relief post operatively.  
 
In our study 4 patients underwent modified Puestow’s as the patient had 
dilated pancreatic duct and stones, and one patient underwent head coring 
procedure (Frey’s Procedure) as the patient had pancreatic head mass. Post 
operatively no patient had pancreatic leak and none developed endocrine 
insufficiency. Post-operative pain relief is 65%. 
 
Frey et al (55) developed a modification of duodenum preserving pancreatic 
head resection which represents a hybrid technique between the Beger and 
Partington Rochelle procedure. In Frey’s procedure rim of pancreatic tissue 
of entire head is preserved and is used to sew to the opened jejunum. Due to 
the safety and relative simplicity of the procedure compared to Beger’s, 
Frey’s procedure is widely accepted in India.  
 
Management of CP is a multidisciplinary task .Medical management is the 
first line of treatment. If patient does not respond to medical treatment, 
patient is subjected to endoscopic / surgical treatment. Surgery is the last 
resort if patient does not respond both to medical and endotherapy. 
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CONCLUSION 
 
In this prospective observational study conducted in 30 patients with chronic 
pancreatitis at PSG Hospital, Coimbatore, the following conclusions were 
made. 
 Most of the patients in their 3rd decade of life. 
 Male preponderance was observed in the ratio 2.7:1 
 Most common etiological factor was alcohol followed by idiopathic . 
 Pain abdomen and epigastric tenderness is the common presentation in 
our study. 
 In our study MRCP was the commonly done imaging modality in 
diagnosing Chronic Pancreatitis as the morphologic changes in the 
glandular tissue, ductal anatomy, degree and level of pancreatic duct 
obstruction are well made out in comparison to CT. In our small study 
group it has been seen that MRCP scores over CT in diagnosis of CP 
having specificity of 100%. 
 Though CT is less specific than MRCP in diagnosing CP, still it is a 
valuable radiological tool in diagnosing CP in centers where MRCP is not 
available. 
 Efficacy of EUS can not be concluded in our study as it was done in only 
two patients. 
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 Medical management is the first line treatment in CP. 
 Out of 30 patients, 5(16.7%)underwent surgery. Four out of five patients 
underwent modified Puestow’s as this is the commonly performed 
surgery for chronic pancreatitis, one underwent head coring (Frey’s 
Procedure). 
 Post operatively pain relief was 65% in our study. 
 None of the patient had pancreatic leak. 
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PROFORMA 
1.   Name    : 
2.   Age     : 
3.   Sex     :  
4.   Clinical Data   : 
 Abdominal pain   
 Diabetes  
 Steatorrhea  
 Loss of weight 
 Jaundice 
5.  Physical findings  
 Epigastric tenderness 
 Epigastric Mass 
 Hepatomegaly 
 Ascites 
6.  Investigations : 
 Blood – Sugar, Urea, Creatinine 
  Serum Amylase, lipase 
  Oral glucose tolerance test 
 Haemogram 
 Liver function test 
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7.  Imaging 
 Plain X ray – abdomen   
 Ultra sound – abdomen  
 CT Scan – abdomen  
 MPCP 
 EUS 
8.  Treatment 
 Medical management 
 Endotherapy 
 Surgery 
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